UBS Upgrades Jazz Pharmaceuticals to Buy, Sets $307 Target
UBS has lifted Jazz Pharmaceuticals to Buy with a $307 price target, arguing that improving fundamentals and a stren...
Explore year-end ETF Tax-Loss Harvesting ideas to harvest losses before year-end, diversify replacements, and sharpen tax efficiency.
25,086 articlesUBS has lifted Jazz Pharmaceuticals to Buy with a $307 price target, arguing that improving fundamentals and a stren...
When cultural moments go big, your wallet pays attention. This article breaks down how Pink and Queen Latifah are exp...
A new nationwide survey finds 49% of divorced americans derailed retirement plans, underscoring how asset division an...
A viral AI-generated forecast circulating online claims XRP could surge by 2030 under a three-scenario framework. Ana...
Old Dominion Freight Line (ODFL) faced an 11.9% drop after a Citi downgrade, despite strong fundamentals. This articl...
History offers a steady compass for investors facing 2026. This article breaks down what history reveals about market...
Analysts convene Thursday to highlight key stock moves ahead of a holiday weekend, with fresh targets and cautions ac...
Micron looks cheaper than its earnings prospects suggest, but a closer look reveals cyclicality, demand swings, and r...
Dell's disciplined AI server strategy contrasts with Super Micro's margin challenges, underscoring two big server bet...
Dreaming of easy flights and hotel stays? Credit cards with bonus travel points offers can unlock big-value redemptio...
Costco is set to report Q2 FY2026 results after the bell, with analysts projecting a solid beat on earnings and reven...
CoreWeave lands a major funding and strategic deals, reinforcing its AI GPU cloud niche, while investors weigh heavy ...